Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)

BACKGROUND/AIMS: It remains to be determined whether switching from adefovir (ADV) to tenofovir (TDF) provides better virological outcomes in patients exhibiting suboptimal responses to ADV plus nucleoside analogue (ADV+NA) therapy for NA-resistant chronic hepatitis B (CHB). METHODS: In this prospec...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Mol Hepatol
Главные авторы: Lee, Hye Won, Park, Jun Yong, Kim, Beom Kyung, Kim, Moon Young, Lee, Jung Il, Kim, Young Suk, Yoon, Ki Tae, Han, Kwang-Hyub, Ahn, Sang Hoon
Формат: Artigo
Язык:Inglês
Опубликовано: The Korean Association for the Study of the Liver 2016
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266340/
https://ncbi.nlm.nih.gov/pubmed/27880997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0037
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы